Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety and efficacy of lapatinib taken together with
capecitabine in Japanese patients. The study will proceed in two phases; the first
phase(Part1) will lead to an evaluation of the mainly tolerability as well as PK parameters.
If there are no major safety concerns in Part 1, the study will move into the second phase
(Part 2) to further evaluate the safety and clinical activity.